Angela Vasaturo, PhD; Senior Scientist, Ultivue
Lorcan Sherry, PhD; Chief Science Officer, OracleBio
Broadcast via The Pathologist, November 2020
Multiplex staining and image analysis are being increasingly deployed for immuno-oncology (I/O) evaluations to investigate and unravel the complexity of immune cell/tumor cell interactions in the tumor microenvironment (TME) and in discovering novel predictive biomarkers for targeted immunotherapy. Immune checkpoint inhibitor treatment, guided by PD-L1 and PD-1 tissue expression assessed by immunohistochemistry, has already shown to improve outcomes for non-small cell lung carcinoma (NSCLC) and colorectal cancer (CRC) metastatic patients. During this webinar, we’ll present a workflow utilizing an 8-plex staining protocol and detailed image analysis approach for the comprehensive assessment of the immune cell types and interactions within the TME, including co-localization and spatial phenotyping analysis in NSCLC and CRC tumor types.
- A fast, optimized and validated 8-plex multiplex immunofluorescence staining protocol and a comprehensive image analysis can be applied to a broad range of cancer types in order to characterize the immune contexture.
- The ability to carry out multiparameter cellular analysis facilitates the delivery of key cell phenotypes as well as their functional status, thereby leading to greater understanding of tumor biology.
More from OracleBio:
Quantitative spatial phenotyping of the tumor microenvironment in NSCLC tissue microarray cores using 6-plex multiplex imaging technology and AI-powered phenotyping analysis
ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.This poster, produced in collaboration with Akoya Biosciences, is presented at SITC 2022, Boston, USA. The aim of this study was to utilize Akoya’s multiplexed imaging technology and...
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach
OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022. The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio. The work involved multiplex...
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
Find out more about our Multiplex IF Analysis
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more